Estados Unidos · Plataformas y datos · MarketBeat

Pfizer (NYSE:PFE) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Publicado por MarketBeat · Estados Unidos hace 1 h

Royal Bank Of Canada raised their price objective on Pfizer from $25.00 to $28.00 and gave the stock a "sector perform" rating in a report on Wednesday.

Leer el artículo completo en MarketBeat Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketbeat.com)

Pfizer (NYSE:PFE) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

También te puede interesar

Ralliant Corporation Non-GAAP EPS of $0.93, revenue of $620M

Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript

These 12 stocks are good bets to beat the 10-year Treasury over the next decade

Eversource Energy earnings on deck after Q2 miss, estimate cuts

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop

Sherrod Brown wins Ohio despite crypto’s costliest $63 million bet

Pfizer (NYSE:PFE) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

Compartir

También te puede interesar

Ralliant Corporation Non-GAAP EPS of $0.93, revenue of $620M

Novo Nordisk (NVO) Q3 2026 Earnings Call Transcript

These 12 stocks are good bets to beat the 10-year Treasury over the next decade

Eversource Energy earnings on deck after Q2 miss, estimate cuts

10-year Treasury yield slides as traders mull over Democrats' midterm victories, oil prices drop

Sherrod Brown wins Ohio despite crypto’s costliest $63 million bet